Wall Street Grand About Us

Featured Small Cap Stock Profiles

Stock Market Multimedia Section

Investment Information & Resources

Small-Cap Investment Services

Wall Street Grand Contact Information


Explosive penny stock list for those looking for huge gains! Join our FREE newsletter and find out why our members are consistently receiving penny stock picks that make BIG profits!




"Wall Street Grand Releases a Brand New Must See Economic Documentary Titled 'Melt Up'"
Featuring an Exclusive interview with Gerald Celente, along with Peter Schiff, Ron Paul, Michael Lewis, Alex Jones, John Williams and more...

Recent WSG Performance:      GULF RESOURCES - GFRE $11.49 (+1251%)      APOLLO GOLD - AGT $0.59 (+392%)      GREEN STAR - GSAE $1.79 (+795%)      IVANHOE MINES - IVN $14.94 (+259%)      FRESHWATER - FWTC $0.20 (+471%)      CHINA AGRITECH - CAGC $31.44 (+1037%)      BULLION MONARCH - BULM $0.97 (+177%)      BIONEUTRAL GROUP - BONU $3.50 (+695%)      LINKWELL CORP - LWLL $0.24 (+380%)      DRD GOLD LIMITED - DROOY $10.59 (+220%)      JAGUAR MINING - JAG $12.76 (+465%)      AGFEED INDUSTRIES - FEED $7.96 (+512%)


    Nutra Pharma Corporation - Stock Symbol: (NPHC.OB)


    Visit Company Website: http://www.nutrapharma.com





Ever since we recently sent out on our new long term pharma play ARYC we have received a ton of inquiries looking for a similar bio-tech company that is more of a short term profit pick. After looking all week we finally discovered what we believe to be the best company that we believe has the most upside potential in the short term for our club.

Our new big pick is Nutra Pharma trading under ticker symbol NPHC on the OTCBB!

NPHC operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases.

The company, through its subsidiaries, carries out basic drug discovery research and clinical development, and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process.

Did you know that Pain is the single most common reason patients seek medical care and accounts for half of all physician office visits in the United States?! 




According to the American Pain Foundation, each year, more than 25 million people in the United States experience acute pain as a result of injury or surgery. Additionally, more than 50 million people in the United States are affected by ongoing chronic pain!

NPHC is positioned magnificently to capitalize on this massive market!

Currently, NPHC offers several drug products for sale for the treatment of pain. The first exciting drug is Cobroxin which is the FIRST over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain! Cobroxin is already available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis!

This is HUGE! NPHC is already generating revenue and they've already started selling their Cobroxin in CVS since this past March! and guess what... the Company expects to start selling their new drug THIS MONTH in non other then Walgreens


The next exciting drug that NPHC developed is their Nyloxin Rx, the ONLY non-narcotic and non-addictive treatment for severe (Stage 3) pain!

NPHC is anticipating its Nyloxin Rx, a Prescription Strength STAGE 3 PAIN RELIEF to be available for distribution throughout the United States THIS YEAR!

As a prescription-only product, Nyloxin Rx will only be available through physicians, hospitals, and pharmacies.

Both Cobroxin and Nyloxin were developed by Nutra Pharmas wholly-owned drug discovery subsidiary, ReceptoPharm.

In addition to manufacturing Cobroxin and Nyloxin, ReceptoPharm is also developing proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), and Human Immunodeficiency Virus (HIV), and pain in humans.  Think about the revenue potential in each of these markets!!!

Furthermore, just like ARYC our new pick NPHC is in the diagnostic industry! The companys wholly-owned medical devices subsidiary, Designer Diagnostics, engages in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases, such as Nontuberculous Mycobacteria (NTM)! In fact, NPHC owns 11 PATENTS for the test kit technology! Check them out- http://www.nutrapharma.com/medical_devices/ip.php

Want more? . . . NPHC also operates a Top- Rated drug production facility! It just keeps getting better and better! NPHC understands that its investment in manufacturing and its first-hand knowledge in drug discovery and development can be very valuable assets to small companies that do not have these resources or capabilities in-house. Working with Nutra Pharma/ReceptoPharm, through its ISO class 5 and GMP certified facilities, will allow these companies to avoid considerable clinical development expenses and allow them to focus on a more important task, expeditiously getting their products to the next stage!

I highly recommend you listen to NPHC's CEO presenting at Nasdaq Marketsite! -

Less than one year ago we saw NPHC make a run from as low as $0.02 to as high as $0.99 for a whopping gain of 4,850%!! These pharma plays are some of the most profitable trades on Wall Street!This is why we love small and micro cap stocks because the potential gains are unfathomable! NPHC has now settled back down to support at the current levels and in our opinion is setting up for its next big bounce. In our next alert we will go over why we feel this could become a HUGE short squeeze play and how our club could potentially profit BIG from this in the short term!

Start your due diligence and prepare for next week!



If you have questions or comments please give us a call during market hours at 1-(888)-925-8247. Please Help spread the Word!!


If you have any questions feel free to email me or call us at 1-(888)-9-Club Grand -or- staff@wallstreetgrand.com

Wall Street Grand's stock profiles are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. Never invest into a stock we discuss unless you are prepared to lose your entire investment. WSG has been compensated Seventy Thousand Dollars for an IR contract on NPHC by the Company. WSG may or may not trade the stocks mentioned in this alert which can effect the price of the stock. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country Everything stated in WSG alerts are based on my opinion. For our full disclosure please visit- http://www.wallstreetgrand.com/disclosure.html



Print This PageAdd to FavoritesShare This PageStock Profiles PageMultimedia PageWSG HomepageContact Us


Home  I  Member Sign-Up  I  List of Penny Stocks  I  Investor Multimedia  I  Stock Alert Archive  I  Wall Street News  I  Investment Services  I  Contact

Copyright 2004 - 2010 Wall Street Grand LLC. All Rights Reserved.  Privacy Policy  I  Disclosure  I  Links  I  Online Brokers  I  Site Map